Wissenschaftliche Arbeiten

Prof. Dr. Evrim Metcalfe

21 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Gorken IB, Bayman E, Balci P, et al. Comparing Ultrasound with Computerized Tomography Images to Choose Electron Energy for Radiotherapy Boost Field in Breast Cancer Patients with Breast Conserving Surgery. J BUON. 2010;15(3):500-503.

    Quelle: Profilseite auf medicana.com.tr

  2. Etiz D, Bayman E, Akcay M, et al. Dosimetric and Clinical Predictors of Acute Esophagitis in Lung Cancer Patients in Turkey Treated with Radiotherapy. Asian Pac J Cancer Prev. 2013;14(7):4223-4228.

    Quelle: Profilseite auf medicana.com.tr

  3. Etiz D, Ataizi FC, Bayman E, et al. Prognostic Value of Osteopontin in Patients Treated with Primary Radiotherapy for Head and Neck Cancer. Asian Pac J Cancer Prev. 2013;14(9):5175-5178.

    Quelle: Profilseite auf medicana.com.tr

  4. Erpolat OP, Alco G, Caglar HB, et al. Comparison of Hematologic Toxicity Between 3DCRT and IMRT Planning in Cervical Cancer Patients After Concurrent Chemoradiotherapy: A National Multi-Center Study. Eur J Gynaecol Oncol. 2014;35(1):62-66.

    Quelle: Profilseite auf medicana.com.tr

  5. Bayman E, Prestwich RJ, Speight R, et al. Patterns of Failure After Intensity-Modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma Using Compartmental Clinical Target Volume Delineation. Clin Oncol (R Coll Radiol). 2014;26(10):636-642.

    Quelle: Profilseite auf medicana.com.tr

  6. Bayman E, Etiz D, Akcay M, Ak G. Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution in Turkey. Asian Pac J Cancer Prev. 2014;15(15):6264-6267.

    Quelle: Profilseite auf medicana.com.tr

  7. Murray L, Sethugavalar B, Robertshaw H, Bayman E, et al. Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks. Clin Oncol (R Coll Radiol). 2015;27(7):401-410.

    Quelle: Profilseite auf medicana.com.tr

  8. Bird D, Scarsbrook AF, Sykes J, et al. Multimodality Imaging with CT, MR and FDG-PET for Radiotherapy Target Volume Delineation in Oropharyngeal Squamous Cell Carcinoma. BMC Cancer. 2015;15:844.

    Quelle: Profilseite auf medicana.com.tr

  9. Metcalfe E, Etiz D. Early Transient Radiation-Induced Brachial Plexopathy in Locally Advanced Head and Neck Cancer. Contemp Oncol (Pozn). 2016;20(1):67-72.

    Quelle: Profilseite auf medicana.com.tr

  10. Metcalfe E, Karaoglanoglu O, Akyazici E. Radiotherapy with or without Temozolomide in Elderly Patients Aged ≥70 Years with Glioblastoma. Contemp Oncol (Pozn). 2016;20(3):251-255.

    Quelle: Profilseite auf medicana.com.tr

  11. Metcalfe E, Aspin L, Speight R, et al. Postoperative (Chemo)Radiotherapy for Oral Cavity Squamous Cell Carcinomas: Outcomes and Patterns of Failure. Clin Oncol (R Coll Radiol). 2017;29(1):51-59.

    Quelle: Profilseite auf medicana.com.tr

  12. Etiz D, Metcalfe E, Akcay M. Multiple Primary Malignant Neoplasms: A 10-Year Experience at a Single Institution from Turkey. J Cancer Res Ther. 2017;13(1):16-20.

    Quelle: Profilseite auf medicana.com.tr

  13. Metcalfe E, Arik D, Oge T, et al. CD105 (Endoglin) Expression as a Prognostic Marker of Angiogenesis in Squamous Cell Cervical Cancer Treated with Radical Radiotherapy. J Cancer Res Ther. 2018;14(6):1373-1378.

    Quelle: Profilseite auf medicana.com.tr

  14. Oktay E, Levent M, et al. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): A Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG). J Cancer Educ. 2020;35(1):69-75.

    Quelle: Profilseite auf medicana.com.tr

  15. Sert F, Metcalfe E, et al. Evaluation of the Radiation Oncologists’ Awareness and Needs about Geriatric Oncology: TROD-13-001 Study. Turk J Oncol. 2023;38(3):295-300. DOI:10.5505/tjo.2023.3978.

    Quelle: Profilseite auf medicana.com.tr

  16. Guzeloz Z, Gorken IB, et al. Evaluation of Treatment Outcomes and Tolerability in Older Patients with Rectal Cancer Treated with Radiotherapy Accompanied by the G-8 Geriatric Score: TROD13-003 Multicenter Study. J Geriatr Oncol. 2024;15(3):101739.

    Quelle: Profilseite auf medicana.com.tr

  17. Cetin IA, Halis H, et al. Definitive Radiotherapy/Chemoradiotherapy Outcomes and Toxicity Profile in Geriatric Patients with Cervical Cancer: Turkish Society for Radiation Oncology Geriatric Oncology Group Study (TROD 013-002). European Journal of Gynaecological Oncology. 2025;46(11):49-59. DOI:10.22514/ejgo.2025.137.

    Quelle: Profilseite auf medicana.com.tr

  18. Çağlar M, Akçay K, et al. Surface Dose Analysis and Dosimetric Comparison of Halcyon Versus Truebeam in Breast Cancer Radiotherapy: An OSL Dosimetry Study. J Appl Clin Med Phys. 2025:e70085. DOI:10.1002/acm2.70085.

    Quelle: Profilseite auf medicana.com.tr

  19. Çağlar M, Ertaş KS, et al. Synthetic CT Generation from CBCT Using Deep Learning for Adaptive Radiotherapy in Prostate Cancer. Front Radiol. 2025;5:1680803.

    Quelle: Profilseite auf medicana.com.tr

  20. Kirli Bolukbas M, Metcalfe E, et al. Determining Elderly-Friendly Radiation Oncology Clinics: A Comparative Analysis of Accessibility and Transport, Physical Environment, and Privacy Aspects (TROD 013-005). BMC Geriatr. 2025;26(1):118.

    Quelle: Profilseite auf medicana.com.tr

  21. Ergen ŞA, Dinçbaş FÖ, Metcalfe E, et al. Failure Patterns and the Influence of the TNM Staging Systems on Prognosis in Limited Disease Small Cell Lung Cancer (SCLC): The Turkish Oncology Group (TOG) Study. Clin Transl Oncol. 2025. DOI:10.1007/s12094-025-04092-9.

    Quelle: Profilseite auf medicana.com.tr